Letermovir Resistance in Hematopoietic Stem Cell Transplant Recipients: The Risks Associated with Cytomegalovirus Prophylaxis
J Infect Dis
.
2020 Mar 16;221(7):1036-1038.
doi: 10.1093/infdis/jiz578.
Author
Scott H James
1
Affiliation
1
Department of Pediatrics, Division of Infectious Diseases, The University of Alabama at Birmingham, Birmingham, Alabama.
PMID:
31784759
PMCID:
PMC7768669
DOI:
10.1093/infdis/jiz578
No abstract available
Keywords:
Cytomegalovirus; antiviral resistance; letermovir.
Publication types
Editorial
Comment
MeSH terms
Acetates
Cytomegalovirus*
Hematopoietic Stem Cell Transplantation*
Quinazolines
Substances
Acetates
Quinazolines
letermovir
Grants and funding
K08 AI108691/AI/NIAID NIH HHS/United States